ArticleGut2017
European consensus conference on faecal microbiota transplantation in clinical practice.
13 registry-linked trialsOpen access · hybridAbstract readConsensus Statement
In one paragraph
Article in Gut, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 13 registered trials, which are not on this map. Cited by 654 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
654citing papers in PubMed, 4 pooled it
67.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Single-Blind, Randomized, Placebo-Controlled Trial of Human Fecal Microbiota Transplantation for the Therapy of Pediatric Ulcerative Colitis and Inflammatory Bowel Disease Unclassified
PediCRaFT: Pediatric Crohn's Disease Fecal Microbiota Transplant Pilot Study
The Effect of Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Multicentre, Placebo-controlled, Randomized, Double Blinded Trial
NCT04406129 early_phase1unknown statusnot on this mapstarted 2021, after this paper: background citation
Effect of Fecal Microbiota Transplantation on Primary Hypertension and the Underlying Mechanism of Gut Microbiome Restoration: a Randomized Clinical Trial
Effect and Safety of Intensive Fecal Microbiota Transplantation on Primary Hypertension: a Randomized Clinical Trial.
Assessment Of Changes In Gut Microbiota Of Patients With Recurrent Clostridioides Difficile Infection After Fecal Microbiota Transplantation: Prospective Study
TRApianto di Microbiota Intestinale in Pazienti Affetti da Sindrome Dell'Intestino IRritabile Senza Stipsi: Studio Clinico Randomizzato Controllato in Singolo Centro
TRApianto di Microbiota Intestinale in Pazienti Affetti da Sindrome Dell'Intestino IRritabile Con Stipsi: Studio Clinico Randomizzato Controllato in Singolo Centro
NCT05917379 phase1 / phase2completednot on this mapstarted 2023, after this paper: background citation
The Safety and Efficacy of Fecal Microbiota Transplantation in Patients With Chronic Insomnia Disorder
Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Randomized, Placebo-controlled, Double-blind Study
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
NCT07172191 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation
Manipulation of the Enteral Microbiome by Fecal Microbiota Transplantation Among Adult Patients With Malignant Hematological Diseases
Who cites it
654 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,112 citations in OpenAlex.
- Efficacy and safety of fecal microbiota transplantation for chronic constipation: a systematic review and meta-analysis integrating pre-post and single-arm evidence.Frontiers in microbiology · 2026Pooled it
- Bibliometric analysis of human microbiota-associated animal model (2005-2025).Frontiers in microbiology · 2026Pooled it
- Pooled it
- Gut microbiota and gastrointestinal tumors: insights from a bibliometric analysis.Frontiers in microbiology · 2025Pooled it
- The Safety, Efficacy, and Feasibility of Fecal Microbiota Transplantation in a Population With Bipolar Disorder During Depressive Episodes: A Pilot Parallel Arm Randomized Controlled Trial: Sécurité, efficacité et faisabilité de la transplantation de microbiote fécal chez une population atteinte de troubles bipolaires, au cours d'épisodes dépressifs : essai pilote contrôlé à répartition aléatoire et à groupes parallèles.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026Trial
- A study on the efficacy and safety of fecal microbiota transplantation as an adjunctive therapy for treating depressive episodes.Scientific reports · 2026Trial
- Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial.Signal transduction and targeted therapy · 2026Trial
- Possible Role of Butyric Acid in Long-Term Symptom Relief in Irritable Bowel Syndrome Patients Following Fecal Microbiota Transplantation.Neurogastroenterology and motility · 2025Trial
- Trial
- Transient colonization with Blastocystis spp. after transmission via fecal microbiota transplantation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Trial
- Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial.Microbiome · 2025Trial
- Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial.BMC medicine · 2024Trial
- Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.NPJ biofilms and microbiomes · 2024Trial
- Recent advances and clinical relevance of microbiome dynamics in health and disease.Gut microbes · 2026Review
- The gut-pancreas axis: microbial dysbiosis as a pathogenic driver of diabetes and pancreatic cancer.Medical oncology (Northwood, London, England) · 2026Review
- Fecal Microbiota Transplantation BeyondJournal of Korean medical science · 2026Review
- Faecal Microbiota Transplantation Reduces Lesion Severity and Medication Use in Canine Atopic Dermatitis: A Randomised, Placebo-Controlled, Double-Blinded Clinical Trial.Veterinary dermatology · 2026Article
- Fecal Microbiota Transplantation and Microbiota-Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions.Clinical pharmacology and therapeutics · 2026Review
- Gut microbiome dynamics in acute infectious diarrhea: A conceptual framework from acute dysbiosis toward precision restoration (Review).Experimental and therapeutic medicine · 2026Review
- Acute Tolerability and Long-Term Surveillance of Fecal Microbiota Transplantation in Children with Autism: A Real-World Study of 604 Procedures.Advances in therapy · 2026Article
594 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
29 authors at 13 institutions in 10 countries.
Giovanni CammarotaDepartment of Gastroenterological Area, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Gianluca IaniroDepartment of Gastroenterological Area, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Herbert TilgDepartment of Internal Medicine I, Gastroenterology, Endocrinology & Metabolism, Medical University, Innsbruck, Austria.
Mirjana Rajilić-StojanovićFaculty of Technology and Metallurgy, Department of Biochemical Engineering and Biotechnology, University of Belgrade, Belgrade, Serbia.
Patrizia KumpDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University, Graz, Austria.
Reetta SatokariFaculty of Medicine, Immunobiology Research Program, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
Harry SokolGastroenterology and Nutrition Department, AP-HP, French Group of Faecal Microbiota Transplantation (GFTF), Saint-Antoine Hospital and UPMC Paris 06, Paris, France.
Perttu ArkkilaDepartment of Clinic of Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Cristina PintusTissues and Cells Area, Italian National Transplant Center (CNT), Rome, Italy.
Ailsa HartDepartment of Gastroenterology, St. Mark's Hospital, London, UK.
Jonathan SegalDepartment of Gastroenterology, St. Mark's Hospital, London, UK.
Marina AloiDepartment of Pediatrics, Pediatric Gastroenterology and Liver Unit, Sapienza University, Rome, Italy.
Luca MasucciLaboratory of Microbiology, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Antonio MolinaroDepartment of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, Institute of Medicine, Sahlgrenska Academy, Gothenburg, Sweden.
Franco ScaldaferriDepartment of Gastroenterological Area, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Giovanni GasbarriniDepartment of Gastroenterological Area, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Antonio Lopez-SanromanGastroenterology and Hepatology Service, Ramón y Cajal University Hospital, Madrid, Spain.
Alexander LinkDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Pieter de GrootDepartment of Internal Medicine, Academic University Medical Center, Amsterdam, The Netherlands.
Willem M de VosFaculty of Medicine, Immunobiology Research Program, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
Christoph HögenauerDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University, Graz, Austria.
Peter MalfertheinerDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.
Eero MattilaDepartment of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland.
Tomica MilosavljevićClinic for Gastroenterology and Hepatology, University of Belgrade and School of Medicine, Clinical Center of Serbia, Belgrade, Serbia.
Max NieuwdorpDepartment of Molecular and Clinical Medicine, Wallenberg Laboratory, University of Gothenburg, Institute of Medicine, Sahlgrenska Academy, Gothenburg, Sweden.
Maurizio SanguinettiLaboratory of Microbiology, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Magnus SimrenDepartment of Internal Medicine and Clinical Nutrition, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.
Antonio GasbarriniDepartment of Gastroenterological Area, "A. Gemelli" Hospital, Catholic University of the Sacred Heart, Rome, Italy.
European FMT Working Group
Università Cattolica del Sacro Cuore · ITUniversity of Helsinki · FIAmsterdam UMC Location University of Amsterdam · NLMedical University of Graz · ATSt Mark's Hospital · GBUniversity Hospital Magdeburg · DEUniversity of Belgrade · RSUniversity of Gothenburg · SEHelsinki University Hospital · FIInnsbruck Medical University · ATInstituto Cajal · ESSapienza University of Rome · ITSorbonne Université · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Faecal microbiota transplantation (FMT) is an important therapeutic option for
Indexed as
Clostridioides difficileFecal Microbiota TransplantationPatient SelectionDonor SelectionEnterocolitis, PseudomembranousEuropeEvidence-Based MedicineHealth FacilitiesHospital UnitsHumansSpecimen HandlingCLINICAL DECISION MAKINGDIARRHOEAL DISEASEENTERIC BACTERIAL MICROFLORA
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
NCT02487238ClinicalTrials.gov
NCT03378167ClinicalTrials.gov
NCT04100291ClinicalTrials.gov
NCT04406129ClinicalTrials.gov
NCT05608447ClinicalTrials.gov
NCT05739825ClinicalTrials.gov
and 7 more above
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.